Feline mammary neoplasia: Biological behavior, diagnosis, and treatment alternatives

Feline Practice

Volumn 25, Issue 2, 1997, Pages 5-11

  Hahn, Kevin A ^a   Adams, William H ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 21744458653     PISSN: 10576614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Dorn CR, Taylor DON, Schneider R, et al: Survey of Animal Neoplasms in Alameda and Contra Costa Counties, California II. Cancer Morbidity in Dogs and Cats From Alameda County. J Natl Cancer Inst 40:307-318, 1968.
2. Moulton JE: Tumors of the Mammary Gland. In: Tumors in Domestic Animals. Ed by JE Moulton. Los Angeles, University of California Press, 1990, pp 547-552.
3. Misdorp W, Romijn A, Hart AA: Feline Breast Tumors: A Case-Control Study of Hormonal Factors. Anticancer Res 11:1793-1797, 1991.
4. Tomlinson L, Barteaux L, Ferns LE, Angelopoulos E: Feline Breast Carcinoma: A Retrospective Evaluation of 17 Cases. Can Vet J 25:435-439, 1984.
5. Hayes HM, Milne KL, Mandell CP: Epidemiological Features of Feline Breast Carcinoma. Vet Rec 108:476-479, 1981.
6. MacEwen EG, Hayes AA, Harvey HJ, et al: Prognostic Factors for Feline Breast Tumors. JAVMA 185:201-204, 1984.
7. Weijer K, Calafat J, Daams JH, et al: Feline Malignant Breast Tumors II. Immunologic and Electron Microscopic Investigations Into a Possible Viral Etiology. J Natl Cancer Inst 52:673-676, 1974.
8. Dorn CR, Taylor DON, Frye FL, Hibbard HH: Survey of Animal Neoplasms in Alameda and Contra Costa Counties, California, I. Methodology and Description of Cases. J Natl Cancer Inst 40:295-305, 1968.
9. Haydan DW, Johnston SD, Wang DT, et al: Feline Breast Hypertrophy/Fibroadenoma Complex: Clinical and Hormonal Aspects. Am J Vet Res 42:1699-1703, 1981.
10. Allen HL: Feline Breast Hypertrophy. Vet Path 10:501-508, 1973.
11. Hernandez FJ, Chertack M, Gage PA: Feline Breast Carcinoma and Progestins. Feline Pract 5:45-48, 1975.
12. Oen EO: The Oral Administration of Megestrol Acetate to Postpone Oestrus in Cats. Nord Vet Med 29:287-291, 1977.
13. Weyer K, Hart AAM: Prognostic Factors in Feline Breast Carcinoma. J Natl Cancer Inst 70:709-716, 1983.
14. Weijer K, Hampe JF, Misdorp W: Breast Carcinoma in the Cat: A Model in Comparative Cancer Research? Arch Chiv Neer 25:413-425, 1973.
15. Weijer K, Head KW, Misdorp W, Hampe JF: Feline Malignant Breast Tumors I. Morphology and Biology: Some Comparisons With Human and Canine Breast Carcinomas. J Natl Cancer Inst 49:1697-1704, 1972.
16. Hayes AA, Mooney S: Feline Mammary Tumors. Vet Clin North Am Small Anim Pract 15:513-520, 1985.
17. McGuire WL: Prognostic Factors in Primary Breast Cancer. Cancer Surv 5:527-536, 1986.
18. Minke JMHM, Cornelisse CJ, Stolwijk JAM, et al: Flow Cytometric DNA Ploidy Analysis of Feline Breast Tumors. Cancer Res 50:4003-4007, 1990.
19. Jeglum KA, DeGuzman E, Young K: Chemotherapy of Advanced Breast Adenocarcinoma in 14 Cats. JAVMA 187:157-160, 1985.
20. Bonnadonna G, Valagussa P: Adjuvant Chemotherapy for Breast Cancer. Sem Surg Oncol 4:250-255, 1988.
21. Stolwijk JAM, Minke JMHM, Rutteman GR, et al: Feline Breast Carcinomas as a Model for Human Breast Cancer II. Comparison of in vivo and in vitro Adriamycin Sensitivity. Anticancer Res 9:1045-1048, 1989.
22. Prop FJ, Weijer K, Spies J, et al: Feline Breast Carcinomas as a Model for Human Breast Cancer I. Sensitivity of Breast Tumor Cells in Culture to Cytostatic Drugs: A Preliminary Investigation of a Predictive Test. Anticancer Res 6:989-984, 1986.
23. Hahn KA, Frazier DL, Cox SK, et al: Effect of Infusion Regime on Doxorubicin Pharmacokinetics in the Cat. JAAHA 1997, in press.
24. Mauldin GE, Mooney SC, Patnaik AK, Mauldin GN: Adjuvant Doxorubicin for Feline Mammary Carcinoma. Proceedings Veterinary Cancer Society, 1994, pp 41-42.
25. Mauldin GN, Matus RE, Patnaik AK: Efficacy and Toxicity of Doxorubicin and Cyclophosphamide Used in the Treatment of Selected Malignant Tumors in 23 Cats. J Vet Int Med 2:60-65, 1988.
26. Cross M, Dexter TM: Growth Factors in Development, Transformation, and Tumorigenesis. Cell 64:271, 1991.
27. Denekamp J: Cell Kinetics and Radiation Biology. Int J Rad Biol 49:357, 1986.
28. Hahn KA, Barnhill MA: Effect of Hypoxia on the Frequency of Bleomycin-Induced Micronuclei. Oncology Reports 3:191-195, 1996.
29. Daniel GB, Hahn KA, Bravo L, Legendre AM: The Effect of a Single Therapeutic Dose of Cisplatin on GFR in Dogs. Oncol Reports. 4:153-156, 1997.
30. 2) in 31 Dogs. Proceedings, Vet Cancer Soc, 1994, pp 43-44.
31. Bravo L, Legendre AM, Hahn KA, et al: Serum Granulocyte Colony-stimulating Factor (G-CSF) and Interteukin-1 (IL-1) Concentrations Following Chemotherapy-Induced Neutropenia in Normal and Tumor-Bearing Dogs. Experimental Hematology 24:11-17, 1996.
32. Hahn KA, Bravo L, Adams WH, Frazier DL: Naturally Occurring Tumors in Dogs as Comparative Models for Cancer Therapy Research. In Vivo 8:133-144, 1994.
33. MacEwen EG: Current Concepts in Cancer Therapy: Biologic Therapy and Chemotherapy. Semin Vet Med Surg 1:5-16, 1986.
34. Rutten VPMG, Misdorp W, Gauthier A, et al: Immunological Aspects of Breast Tumors in Dogs and Cats: A Survey including Own Studies and Pertinent Literature. Vet Immunol Immunopath 26:211-225, 1990.
35. Hahn KA, Richardson RC, Knapp DW: Canine Malignant Breast Neoplasia: Biological Behavior, Diagnosis, and Treatment Alternatives. JAAHA 28:251-256, 1992.
36. MacEwen EG, Hayes AA, Mooney S, et al: Evaluation of Effect of Levamisole on Feline Breast Cancer. J Biol Response Modifiers 5:541-546, 1984.
37. Fox LE, MacEwen EG, Kurzman ID, et al: L-MTP-PE Treatment of Feline Mammary Adenocarcinoma. Proceedings Veterinary Cancer Society, 1994, pp 107-108.
38. Vail DM, MacEwen EG, Kurzman ID, et al: Liposome-Encapsulated Muramyl Tripeptide Phosphatidylethanolamine Adjuvant Immunotherapy for Splenic Hemangiosarcoma in the Dog: A Randomized Multi-Institutional Clinical Trial. Clinical Cancer Research 1:1165-1170, 1995.
39. Fletcher WF: Endocrine Manipulation in Advanced Breast Cancer. In: Advances in Breast and Endocrine Surgery. Ed by JS Najarian, JP Delaney. Chicago, Year Book Medical Publishers, 1986.
40. Rosenthal LJ: Discrepant Estrogen Receptor Protein Levels According to Surgical Techniques. Am J Surg 138:680-681, 1979.
41. Martin PM, Cotard M, Mialot JP, et al: Animal Models for Hormone-Dependent Human Breast Cancer: Relationihip Between Steroid Receptor Profiles in Canine and Feline Breast Tumors and Survival Rate. Cancer Chemother Pharmacol 12:13-17, 1984.
42. Hamilton JM, Else RW, Forshaw P: Oestrogen Receptors in Feline Breast Carcinomas. Vet Rec 99:477-479, 1976.
43. Johnston DS, Hayden DW, Kiang DT, et al: Progesterone Receptors in Feline Breast Adenocarcinomas. Am J Vet Res 45:379-382, 1984.
44. Rutteman GR, Blankenstein MA, Minke J, Misdorp W: Steroid Receptors in Breast Tumors of the Cat (suppl 1). Acta Endocrinol Copenh 125:32-37, 1991.
45. Elling H, Ungemach FR: Progesterone Receptors in Feline Breast Cancer Cytosol. J Cancer Res Clin Oncol 100:325-327, 1981.